Singapore
The company's expertise lies in understanding the hurdles and pain-points of conducting a clinical trial. It recognizes the criticality of ensuring that medical devices, equipment, and supplies reach sites on time, are installed & calibrated (IQ OQ PQ), and site officials are trained on ‘instructions of use’. Intrinseque Health emphasizes the development of a robust supply chain strategy and management of ancillary supplies at sites throughout the entire duration of a clinical trial, thereby minimizing the impact on study timelines.
Operating in a highly regulated industry, Intrinseque Health acknowledges that every region/country presents its own unique regulatory and logistical challenges for clinical studies. The company provides project management-based, global clinical supply chain solutions to its clients, addressing the complexities associated with product, supplies, and equipment availability for a clinical study. Their operation methodology is focused on the development of a pressure-tested, fool-proof, and cost-effective clinical supply chain strategy for each clinical trial/project. The organization believes in engaging early with its clients to address their clinical and non-clinical supply needs before the initiation of a clinical trial.
Founded in 2020, Intrinseque Health operates in the biopharma and pharmaceutical industries with its headquarters located in Singapore. As per the available information, the company's last investment details and investors are not specified at this time.
